Patients receiving treatment in Blue House, a clinic on the edge of Mathare, one of the Kenyan capital Nairobi's more violent slums, where MSF treats people with TB and HIV. Photograph by Bruno De Cock
Report |

DR-TB Drugs Under the Microscope, 1st Edition

English (ENG) and Russian (RU) versions available to download

Photograph by Bruno De Cock

MSF's new report outlines the issues surrounding access to DR-TB drugs, including - the limited number of quality sources, including few quality assured producers and limited sources of the active pharmaceutical ingredient; limited affordability, due to drug price variables and prices that have increased ; and the need to produce drugs suitable for children and people with HIV.

Additional publications in the DR-TB Drugs Under the Microscope report series are available here.

Learn more about MSF’s work to improve access to lifesaving TB treatment.

DR-TB Drugs Under the Microscope